Gamble Jones Investment Counsel’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.39M | Sell |
9,934
-1,301
| -12% | -$185K | 0.11% | 94 |
|
|
2022
Q3 | $1.44M | Sell |
11,235
-351
| -3% | -$50.6K | 0.12% | 87 |
|
|
2022
Q2 | $1.63M | Sell |
11,586
-100
| -0.9% | -$14.3K | 0.12% | 87 |
|
|
2022
Q1 | $1.63M | Buy |
11,686
+10
| +0.1% | +$1.53K | 0.1% | 98 |
|
|
2021
Q4 | $2.04M | Sell |
11,676
-1,596
| -12% | -$266K | 0.12% | 89 |
|
|
2021
Q3 | $2.2M | Sell |
13,272
-72
| -0.5% | -$12.4K | 0.14% | 83 |
|
|
2021
Q2 | $2.4M | Sell |
13,344
-932
| -7% | -$170K | 0.16% | 82 |
|
|
2021
Q1 | $2.75M | Sell |
14,276
-23
| -0.2% | -$4.43K | 0.19% | 78 |
|
|
2020
Q4 | $2.89M | Buy |
14,299
+1
| +0% | +$207 | 0.2% | 75 |
|
|
2020
Q3 | $3M | Buy |
14,298
+988
| +7% | +$220K | 0.22% | 71 |
|
|
2020
Q2 | $2.92M | Sell |
13,310
-79
| -0.6% | -$15.8K | 0.23% | 67 |
|
|
2020
Q1 | $2.32M | Sell |
13,389
-25,022
| -65% | -$4.13M | 0.21% | 71 |
|
|
2019
Q4 | $5.9M | Sell |
38,411
-2,191
| -5% | -$327K | 0.46% | 48 |
|
|
2019
Q3 | $6.17M | Sell |
40,602
-148
| -0.4% | -$23.4K | 0.51% | 46 |
|
|
2019
Q2 | $6.24M | Sell |
40,750
-569
| -1% | -$86.9K | 0.53% | 45 |
|
|
2019
Q1 | $6.63M | Buy |
41,319
+207
| +0.5% | +$32.1K | 0.59% | 43 |
|
|
2018
Q4 | $6.34M | Buy |
41,112
+4
| +0% | +$623 | 0.64% | 35 |
|
|
2018
Q3 | $6.18M | Buy |
41,108
+293
| +0.7% | +$41.6K | 0.57% | 43 |
|
|
2018
Q2 | $5.52M | Buy |
40,815
+21,203
| +108% | +$2.62M | 0.55% | 42 |
|
|
2018
Q1 | $2.61M | Sell |
19,612
-382
| -2% | -$51.3K | 0.26% | 76 |
|
|
2017
Q4 | $2.97M | Buy |
19,994
+5
| +0% | +$680 | 0.28% | 68 |
|
|
2017
Q3 | $2.64M | Buy |
19,989
+836
| +4% | +$112K | 0.27% | 77 |
|
|
2017
Q2 | $2.55M | Buy |
19,153
+65
| +0.3% | +$8.77K | 0.27% | 72 |
|
|
2017
Q1 | $2.57M | Sell |
19,088
-1,475
| -7% | -$191K | 0.27% | 73 |
|
|
2016
Q4 | $2.47M | Sell |
20,563
-383
| -2% | -$45.2K | 0.27% | 70 |
|
|
2016
Q3 | $2.62M | Sell |
20,946
-174
| -0.8% | -$22.8K | 0.28% | 66 |
|
|
2016
Q2 | $2.92M | Sell |
21,120
-274
| -1% | -$35.5K | 0.32% | 57 |
|
|
2016
Q1 | $2.7M | Sell |
21,394
-576
| -3% | -$73.2K | 0.3% | 64 |
|
|
2015
Q4 | $2.79M | Sell |
21,970
-1,001
| -4% | -$124K | 0.31% | 63 |
|
|
2015
Q3 | $2.65M | Sell |
22,971
-1,777
| -7% | -$199K | 0.31% | 62 |
|
|
2015
Q2 | $2.57M | Sell |
24,748
-369
| -1% | -$39.8K | 0.27% | 73 |
|
|
2015
Q1 | $2.77M | Sell |
25,117
-351
| -1% | -$38.1K | 0.29% | 66 |
|
|
2014
Q4 | $2.65M | Buy |
25,468
+57
| +0.2% | +$5.7K | 0.27% | 66 |
|
|
2014
Q3 | $2.44M | Sell |
25,411
-312
| -1% | -$28.2K | 0.27% | 71 |
|
|
2014
Q2 | $2.35M | Buy |
25,723
+536
| +2% | +$48K | 0.26% | 70 |
|
|
2014
Q1 | $2.22M | Sell |
25,187
-359
| -1% | -$31.5K | 0.26% | 70 |
|
|
2013
Q4 | $2.37M | Sell |
25,546
-304
| -1% | -$27.4K | 0.28% | 63 |
|
|
2013
Q3 | $2.11M | Sell |
25,850
-1,184
| -4% | -$100K | 0.27% | 61 |
|
|
2013
Q2 | $2.25M | Buy |
+27,034
| New | +$2.33M | 0.3% | 55 |
|
Other funds holding CLX
AWA
Gamble Jones Investment Counsel's CLX Position: Q4 2022 in Review
Gamble Jones Investment Counsel reduced its Clorox (CLX) stake by 12% in Q4 2022, selling an estimated $185K and leaving 9,934 shares worth $1.39M. The position accounts for 0.11% of the portfolio, ranked #94.
Gamble Jones Investment Counsel first reported a position in CLX in Q2 2013 and has held it in 39 quarters since. The position peaked at $6.63M in Q1 2019. 1,107 funds tracked by Wall St. Rank hold CLX as of Q4 2022.
- Gamble Jones Investment Counsel held 9,934 shares of Clorox worth $1.39M as of Q4 2022.
- Gamble Jones Investment Counsel sold 1,301 Clorox shares in Q4 2022, an estimated $185K.
- Clorox made up 0.11% of Gamble Jones Investment Counsel's portfolio in Q4 2022, its #94 holding.
- Gamble Jones Investment Counsel first reported a position in Clorox in Q2 2013 and has held it in 39 quarters since.
- Gamble Jones Investment Counsel's Clorox position peaked at $6.63M in Q1 2019.
- 1,107 funds tracked by Wall St. Rank held Clorox as of Q4 2022.
Based on Gamble Jones Investment Counsel's 13F filing for Q4 2022, filed 8 Feb 2023.